Skip to content

Metabolic

PCSK9 Inhibitors

PCSK9 inhibitors are cholesterol-lowering medicines used to reduce LDL cholesterol in people with high cardiovascular risk or inherited lipid disorders. They block the PCSK9 protein, allowing more LDL receptors to remain on liver cells and clear more LDL from the bloodstream.

Interactions

Supplement interactions on file

No supplement in this library is recorded as interacting with this medication. Coverage is partial — 171 of 216 medications have interaction data, drawn from the 107 supplements written up so far. Absence here is incomplete coverage, not a safety claim.

Browse the supplements that are written up

Trade names
Evolocumab (Repatha), Alirocumab (Praluent)

Diatelos provides general wellness information based on published research. It is not medical advice. Talk to a clinician before starting any new supplement or practice, especially if you have a health condition, are pregnant, or take medication.